MRNA Short-Term Investments History: $3.20B (FY2025)

Fiscal year	Q1	Q2	Q3	Q4
FY26	$3.3B−24.2%	Not reported	Not reported	Not reported
FY25	$4.4B−32.8%	$3.9B−35.9%	$3.4B−35.4%	$3.2B−37.2%
FY24	$6.5B+18.1%	$6.0B+29.0%	$5.2B+12.5%	$5.1B−10.5%
FY23	$5.5B+8.2%	$4.7B−7.3%	$4.6B−12.8%	$5.7B−14.9%
FY22	$5.1B+121.0%	$5.0B+110.5%	$5.3B+58.6%	$6.7B+72.6%

01—History

Short-Term Investments History

Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.

$3.20B

YoY changeLargest recent move+128.8%in FY20Latest −37.2%

02—Ledger

Short-Term Investments, period by period

Period	Value	Change	Source
FY2025	$3.20B	−37.2%	10-K
FY2024	$5.10B	−10.5%	10-K
FY2023	$5.70B	−14.9%	10-K
FY2022	$6.70B	+72.6%	10-K
FY2021	$3.88B	+95.5%	10-K
FY2020	$1.98B	+128.8%	10-K
FY2019	$867.1M	+0.5%	10-K
FY2018	$863.1M	+38.9%	10-K
FY2017	$621.2M	—	10-K

03—Questions

What is short-term investments?

Short-term investments are marketable securities and other investments that can be readily converted to cash within one year.

What is Moderna, Inc.'s current short-term investments?

Moderna, Inc. (MRNA) annual short-term investments for 2025 was $3.20B, a 37.15% decline from 2024. Moderna, Inc. short-term investments for the quarter ending March 31, 2026 was $3.30B.

What was Moderna, Inc.'s short-term investments in 2024?

Moderna, Inc. annual short-term investments for 2024 was $5.10B, a 10.51% decline from 2023.

What was Moderna, Inc.'s short-term investments in 2023?

Moderna, Inc. annual short-term investments for 2023 was $5.70B, a 14.93% decline from 2022.

What is Moderna, Inc.'s 5-year short-term investments CAGR?

Moderna, Inc. short-term investments grew at a compound annual growth rate (CAGR) of 10.06% from FY2020 to FY2025, going from $1.98B to $3.20B over 5 years.

Company: Moderna, Inc.
Ticker: MRNA
Sector: Healthcare
Industry: Biological Products, (No Diagnostic Substances)

Moderna, Inc. Short-Term Investments 2017-2026 | MRNA

Key Statistics